title: Cyclosporine neoral in liver transplant recipients.
authors.affiliation: Toronto Hospital-University of Toronto, Ontario, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Levy
authors.forename: I
authors.initials: I
authors.lastname: Altraif
authors.forename: M
authors.initials: M
authors.lastname: Rezieg
authors.forename: S
authors.initials: S
authors.lastname: Asfar
authors.forename: J
authors.initials: J
authors.lastname: Rochon
authors.forename: D
authors.initials: D
authors.lastname: Freeman
authors.forename: P Y
authors.initials: PY
authors.lastname: Wong
authors.forename: L
authors.initials: L
authors.lastname: Banks
authors.forename: C
authors.initials: C
authors.lastname: Roach
authors.forename: K
authors.initials: K
authors.lastname: Engel
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004435:Eating; D005215:Fasting; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D008991:Monitoring, Physiologic
chemical_list: D016572:Cyclosporine